Methylselenocysteine treatment leads to diselenide formation in human cancer cells: evidence from X-ray absorption spectroscopy studies.
about
XAS studies of Se speciation in selenite-fed rats.Selenium metabolism in cancer cells: the combined application of XAS and XFM techniques to the problem of selenium speciation in biological systems.Selenium compounds, apoptosis and other types of cell death: an overview for cancer therapy.Tracing cytotoxic effects of small organic Se species in human liver cells back to total cellular Se and Se metabolites.XAS and XFM studies of selenium and copper speciation and distribution in the kidneys of selenite-supplemented rats.Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development.
P2860
Methylselenocysteine treatment leads to diselenide formation in human cancer cells: evidence from X-ray absorption spectroscopy studies.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Methylselenocysteine treatment ...... sorption spectroscopy studies.
@en
Methylselenocysteine treatment ...... sorption spectroscopy studies.
@nl
type
label
Methylselenocysteine treatment ...... sorption spectroscopy studies.
@en
Methylselenocysteine treatment ...... sorption spectroscopy studies.
@nl
prefLabel
Methylselenocysteine treatment ...... sorption spectroscopy studies.
@en
Methylselenocysteine treatment ...... sorption spectroscopy studies.
@nl
P50
P356
P1433
P1476
Methylselenocysteine treatment ...... sorption spectroscopy studies.
@en
P2093
Jade B Aitken
P304
P356
10.1021/BI201462U
P407
P577
2012-01-17T00:00:00Z